1. James P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY;
2. Helen Diller Family Comprehensive Cancer Center, Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA;
3. Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC;
4. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
5. Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, NJ;
6. Department of Psychiatry,
7. Department of Family Medicine, and
8. Department of Medicine, Palliative Care, University of Rochester School of Medicine and Dentistry, Rochester, NY;
9. Section on Hematology and Oncology, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC; and
10. Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA